Verve Therapeutics
VERV
#6558
Rank
HK$4.22 B
Marketcap
HK$49.85
Share price
-0.16%
Change (1 day)
-31.30%
Change (1 year)

EPS for Verve Therapeutics (VERV)

EPS in 2023 (TTM): -HK$24.85

According to Verve Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$24.65. In 2022 the company made an earnings per share (EPS) of -HK$22.71 a decrease over its 2021 EPS that were of -HK$19.66.

EPS history for Verve Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$24.859.42%
2022-HK$22.7115.54%
2021-HK$19.6661.32%
2020-HK$12.18